About Talent Biotech
Talent Biotech is a company based in Bnei Brak (Israel) founded in 2014 was acquired by Kalytera Therapeutics in January 2017.. Talent Biotech operates in a competitive market with competitors including GigaGen, Xenikos, REGiMMUNE, Medeor Therapeutics and Veloxis, among others.
- Headquarter Bnei Brak, Israel
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Kalytera Therapeutics
(Jan 15, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Talent Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Talent Biotech
Talent Biotech has secured backing from 1 investor. Prominent investors backing the company include Kalytera Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cannabinoid therapies for osteoporosis and bone healing are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Talent Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Talent Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Talent Biotech Comparisons
Competitors of Talent Biotech
Talent Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GigaGen, Xenikos, REGiMMUNE, Medeor Therapeutics and Veloxis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
|
| domain | founded_year | HQ Location |
Developer of toxin-loaded antibodies for T-cell mediated diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for immune diseases are developed via targeted immunomodulators.
|
|
| domain | founded_year | HQ Location |
Personalised cellular therapeutics are developed to enhance kidney transplant outcomes.
|
|
| domain | founded_year | HQ Location |
Specialty pharmaceuticals for transplant and cardiovascular needs are developed globally.
|
|
| domain | founded_year | HQ Location |
Pioneers drugs for antibody-mediated autoimmune diseases via Antibody-Catch technology platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Talent Biotech
When was Talent Biotech founded?
Talent Biotech was founded in 2014.
Where is Talent Biotech located?
Talent Biotech is headquartered in Bnei Brak, Israel. It is registered at Bnei Brak, Tel Aviv District, Israel.
What does Talent Biotech do?
Talent Biotechs was founded in 2014 in Bnei Brak, Israel, within the biotechnology sector. Operations center on cannabinoid-based treatments, with initial efforts directed toward cannabidiol extracted from cannabis for preventing and treating Graft versus Host Disease. In February 2017, the company was acquired by Kalytera for over 10 million, enabling plans to progress the GvHD program into FDA phase 2b clinical studies.
Who are the top competitors of Talent Biotech?
Who are Talent Biotech's investors?
Talent Biotech has 1 investor. Key investors include Kalytera Therapeutics.